Pfizer Profit Dips on Ease in Demand for Lipitor
Wednesday, April 29, 2009 - 00:36
in Mathematics & Economics
As Pfizer sails toward its merger with Wyeth, it is hitting headwinds from patent expirations and weakening in sales in some key products, including Lipitor.